Skin Laboratory PCL (BKK:SKIN)
1.060
-0.030 (-2.75%)
At close: May 22, 2026
Skin Laboratory PCL Balance Sheet
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 64.97 | 72.36 | 27.84 | 41.21 | 36.83 | 44.26 |
Short-Term Investments | - | 5.41 | 1.94 | 8.34 | 1.14 | 0.54 |
Cash & Short-Term Investments | 64.97 | 77.77 | 29.78 | 49.55 | 37.97 | 44.8 |
Cash Growth | 118.16% | 161.14% | -39.89% | 30.50% | -15.25% | -15.81% |
Accounts Receivable | 20.69 | 16.52 | 26.9 | 26.82 | 32.34 | 23.56 |
Other Receivables | - | 2.69 | 0.09 | 0.07 | 0.52 | 0.86 |
Receivables | 20.69 | 19.21 | 26.99 | 26.88 | 32.85 | 25.3 |
Inventory | 21.84 | 19.22 | 19.28 | 18.41 | 22.69 | 27.97 |
Other Current Assets | 0.19 | 0.66 | 0.15 | 0.41 | - | - |
Total Current Assets | 107.7 | 116.86 | 76.2 | 95.25 | 93.51 | 98.07 |
Property, Plant & Equipment | 2 | 2.39 | 3.61 | 5.55 | 4.67 | 4.76 |
Other Intangible Assets | 0.29 | 0.3 | 0.33 | 0.17 | 0.06 | 0.05 |
Long-Term Deferred Tax Assets | 3.25 | 3.61 | 4.64 | 3.33 | 3.26 | 0.45 |
Other Long-Term Assets | 0.37 | 0.37 | 0.37 | 0.52 | 0.17 | 0.07 |
Total Assets | 113.61 | 123.53 | 85.15 | 104.81 | 101.67 | 103.4 |
Accounts Payable | 15.23 | 8.28 | 9.57 | 11.15 | 16.36 | 14.5 |
Accrued Expenses | - | 4.65 | 4.13 | 5.99 | 2.67 | 4.33 |
Current Portion of Leases | 1.12 | 1.33 | 1.24 | 1.5 | 0.74 | 0.26 |
Current Income Taxes Payable | - | - | 3.07 | 2.29 | 0.85 | 2.08 |
Other Current Liabilities | 0.46 | 4.75 | 1.51 | 6.95 | 5.52 | 0.83 |
Total Current Liabilities | 16.81 | 19.01 | 19.52 | 27.88 | 26.15 | 22 |
Long-Term Leases | - | 0.12 | 1.45 | 2.95 | 2.79 | 2.41 |
Pension & Post-Retirement Benefits | 3.39 | 3.21 | 2.5 | 1.92 | 1.12 | 0.8 |
Total Liabilities | 20.19 | 22.34 | 23.46 | 32.74 | 30.06 | 25.21 |
Common Stock | 72 | 72 | 50 | 1 | 1 | 1 |
Additional Paid-In Capital | 28.17 | 28.17 | - | - | - | - |
Retained Earnings | -6.76 | 1.02 | 11.69 | 71.07 | 70.6 | 77.19 |
Shareholders' Equity | 93.42 | 101.19 | 61.69 | 72.07 | 71.6 | 78.19 |
Total Liabilities & Equity | 113.61 | 123.53 | 85.15 | 104.81 | 101.67 | 103.4 |
Total Debt | 1.12 | 1.45 | 2.68 | 4.45 | 3.54 | 2.67 |
Net Cash (Debt) | 63.85 | 76.33 | 27.1 | 45.09 | 34.43 | 42.13 |
Net Cash Growth | 135.63% | 181.68% | -39.91% | 30.98% | -18.28% | -7.00% |
Net Cash Per Share | 0.52 | 0.68 | 0.63 | 22.55 | 17.21 | 21.06 |
Filing Date Shares Outstanding | 144 | 144 | 100 | 2 | 2 | 2 |
Total Common Shares Outstanding | 144 | 144 | 100 | 2 | 2 | 2 |
Working Capital | 90.89 | 97.85 | 56.69 | 67.37 | 67.36 | 76.08 |
Book Value Per Share | 0.65 | 0.70 | 0.62 | 36.04 | 35.80 | 39.10 |
Tangible Book Value | 93.13 | 100.89 | 61.36 | 71.9 | 71.54 | 78.14 |
Tangible Book Value Per Share | 0.65 | 0.70 | 0.61 | 35.95 | 35.77 | 39.07 |
Buildings | - | - | - | - | 1.01 | 1.01 |
Machinery | - | 2.36 | 1.88 | 2.31 | - | 0.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.